WASHINGTON, March 28,
2024 /PRNewswire/ -- Building on the legacy of
15 years as a growing and impactful foundation serving the rare
disease community, the EveryLife Foundation for Rare Diseases
announces the appointment of Michael
Pearlmutter into the new role of Chief Executive Officer of
the foundation. Michael is a distinguished executive with more than
13 years of leadership experience in mission-driven organizations,
most recently as the Executive Director of the Cerebral Palsy
Alliance Research Foundation (CPARF). While there, he was
instrumental in significantly expanding research initiatives,
boosting fundraising efforts, and initiating both the Remarkable US
disability technology accelerator program and the strategic
partnership with the Cerebral Palsy Research Network (CPRN). During
his tenure, CPARF saw a remarkable 475% increase in grant
applications and 140% rise in fundraising, including securing three
of the organization's largest donations.
Michael's appointment is an instrumental part of EveryLife
Foundation's vision to expand the foundation's donor community and
activities as it embarks on its next era. The Foundation seeks to
double its budget and reach over the next 5-7 years, to support a
bold new vision that not only builds on its highly successful
Community Congress and Rare Disease Week but expands its ability to
change rare disease outcomes. New initiatives will address science
policies, including novel therapy platforms, such as gene and cell
therapies; regulatory science strategies to address new clinical
trial approaches; and the use of AI and big data to design and
develop methods to shorten the diagnostic odyssey and reduce
disease impact on patients and caregivers living with rare disease.
Building on our groundbreaking studies in both areas, these
programs will allow for the expansion of the EveryLife community to
further illustrate the case for rare disease as a public health
imperative.
A graduate of the United States Naval
Academy, Michael brings a passion and dedication to service.
Michael also has firsthand experience with a rare disease,
furthering his dedication and personal connection to the mission of
the EveryLife Foundation. His own experiences bring a deep
understanding and empathy for challenges faced by rare disease
patients, including the often-prolonged diagnostic odyssey that
many endure.
Vicki Seyfert-Margolis, Chair of
the Board of Directors at the EveryLife Foundation for Rare
Diseases, expressed excitement about Pearlmutter's appointment,
stating, "Michael's dynamic leadership and personal connection to
the rare disease community make him the ideal choice to lead our
Foundation. His visionary approach and unwavering commitment are
exactly what we need to grow the foundation and drive awareness
that rare disease is a public health crisis that impacts everyone,
and that innovations in rare disease almost lead the way in
development of new treatments for diseases affecting many."
Upon his appointment, Pearlmutter shared his enthusiasm, "I am
excited to be stepping into the role of CEO at the EveryLife
Foundation for Rare Diseases. As someone who has personally
navigated the challenges of a rare blood disorder, I am deeply
motivated to harness our collective power to make a significant
impact. Every day, I am grateful that my diagnosis comes with a
treatment and a positive prognosis, but I know that the journey of
every individual who has a rare disease is unique. Together, we'll
foster innovation, strengthen partnerships, and accelerate progress
to transform the lives of the rare disease community. I am filled
with energy, optimism, and determination as we embark on this
journey together."
Michael's extensive background in nonprofit management and
fundraising, coupled with his innovative leadership, positions him
perfectly to lead the Foundation in broadening its vision to
advance treatments and cures for rare diseases.
About:
EveryLife Foundation for Rare Diseases is a nonprofit, nonpartisan
organization dedicated to advancing the development of treatment
and diagnostic opportunities for rare disease patients through
science-driven public policy. The Foundation works to improve the
lives of the millions of Americans suffering from rare diseases by
advocating for policies that foster innovation and remove barriers
to life-saving treatments.
Founded in 2009 and headquartered in Washington, DC, the EveryLife Foundation for
Rare Diseases has programs throughout the
United States. To learn more, visit
EveryLifeFoundation.org.
For additional information visit everylifefoundation.org/news/.
Follow us on Facebook, Twitter, Instagram, and LinkedIn.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/everylife-foundation-for-rare-diseases-welcomes-michael-pearlmutter-as-ceo-302102040.html
SOURCE EveryLife Foundation for Rare Diseases